tiprankstipranks
Trending News
More News >

Tracey L McCain Insider Profile

4 Followers
Tracey L McCain, EVP & CLO at Blueprint Medicines, holds 0.00 shares in Blueprint Medicines (Ticker: BPMC), holds 12.55K shares in Kiniksa Pharmaceuticals (Ticker: KNSA), holds ― shares in ImmunoGen (Ticker: IMGN).
tipranks
Tracey L McCain

Tracey L McCain
Blueprint Medicines (BPMC)
EVP & CLO

Ranked #90,922 out of 106,487 Corporate Insiders

Profitable Transactions

60%
3 out of 5 Profitable Transactions

Average Return

-29.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$590K
100.00%
A breakdown of Tracey L McCain's holdings

Insider Roles

Kiniksa Pharmaceuticals
(KNSA)
Director
Roles that Tracey L McCain holds in companies

Most Profitable Insider Trade

Stock:
Blueprint Medicines
(BPMC)
Rating:Informative Sell
Date:Mar 05, 2021 - Mar 05, 2022
Return:+40.50%
The most profitable trade made by Tracey L McCain

Tracey L McCain's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BPMC
Blueprint Medicines
Jul 21, 2025
Uninformative Buy
$0.00
Kiniksa Pharmaceuticals
Jun 05, 2025
Director
Uninformative Buy
91.64K
$589.91K
IMGN
ImmunoGen
List of latest transactions for each holding click on a transaction to see Tracey L McCain's performance on stock

Tracey L McCain insider profile FAQ

What is the percentage of profitable transactions made by Tracey L McCain?
The percentage of profitable transactions made by Tracey L McCain is 60%.
    What is the average return per transaction made by Tracey L McCain?
    The average return per transaction made by Tracey L McCain is -29.60%.
      What stocks does Tracey L McCain hold?
      Tracey L McCain holds: BPMC, KNSA, IMGN stocks.
        What was Tracey L McCain’s latest transaction?
        Tracey L McCain latest transaction was an Uninformative Buy of ―.
          What was Tracey L McCain's most profitable transaction?
          Tracey L McCain’s most profitable transaction was an Informative Sell of BPMC stock on March 5, 2021. The return on the trade was 40.50%.
            What is Tracey L McCain's role in Blueprint Medicines?
            Tracey L McCain's role in Blueprint Medicines is EVP & CLO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.